Interestingly, studies in the heart, the liver and in pancreatic insulin-secreting beta-cells have affirmed SERCA pumps as key players in the pathophysiology of type-2 diabetes (T2D) [[17], [18], [19], [20], [21]]. The gene discussed is INS; the disease is type 2 diabetes mellitus.